Global In-Silico Drug Discovery Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global In-Silico Drug Discovery Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global In-Silico Drug Discovery market size was valued at US$ 2313 million in 2024 and is forecast to a readjusted size of USD 4953 million by 2031 with a CAGR of 11.6% during review period.

In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.

The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.

This report is a detailed and comprehensive analysis for global In-Silico Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global In-Silico Drug Discovery market size and forecasts, in consumption value ($ Million), 2020-2031

Global In-Silico Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global In-Silico Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global In-Silico Drug Discovery market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for In-Silico Drug Discovery

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global In-Silico Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schrödinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

In-Silico Drug Discovery market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software

Market segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others

Market segment by players, this report covers
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe In-Silico Drug Discovery product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of In-Silico Drug Discovery, with revenue, gross margin, and global market share of In-Silico Drug Discovery from 2020 to 2025.

Chapter 3, the In-Silico Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and In-Silico Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of In-Silico Drug Discovery.

Chapter 13, to describe In-Silico Drug Discovery research findings and conclusion.